Pharma Signals

Pharma Signals helps you follow drug regulatory events without digging through multiple agency websites.

Track official FDA and EMA updates, monitor the companies and drugs you care about, and review each event with structured context designed for faster understanding. Pharma Signals is built for biotech investors, healthcare analysts, and professionals who want a cleaner way to stay on top of regulatory developments.

Use Pharma Signals to:

• Follow recent FDA and EMA regulatory events in a live, structured feed
• Track watchlist companies and drugs in one place
• Review high-impact events faster
• Open original source links directly from each event
• Get alerts for important developments on names you follow
• See context around what happened and why it may matter
• Review portfolio-related regulatory signals in one dedicated view

Key features:

• Official regulatory feed
  Browse recent public-source events from major drug regulators, including approvals, safety actions, label changes, and other important updates.
• Watchlists for companies and drugs
  Track the biotech and pharma names that matter to you, including both company-level and drug-level coverage.
• High-impact event view
  Surface notable regulatory developments faster with a dedicated high-impact section.
• Event detail with source links
  Each event is tied back to public regulator sources so you can verify the original announcement yourself.
• Personalized alerts
  Receive notifications for major watchlist developments and stay informed when new signals appear.
• Portfolio context
  Connect regulatory events to companies you follow and review how reported events fit into your broader monitoring workflow.

Pharma Signals focuses on public regulatory information and structured context. It is not a trading app, and it does not provide investment advice.

Some features may require a Premium subscription, including advanced alerts, historical analytics, and AI-powered summaries.